<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01834092</url>
  </required_header>
  <id_info>
    <org_study_id>H-4-2012-085</org_study_id>
    <nct_id>NCT01834092</nct_id>
  </id_info>
  <brief_title>Study of the Glycocalyx in Abdominal Aortic Aneurysm</brief_title>
  <acronym>Endo_eAAA</acronym>
  <official_title>Measurement of the Endothelial Function in Patients With a Abdominal Aortic Aneurism.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators want to measure the degradation of the endothelial glycocalyx before and
      after clamping the aorta, in patients operated for a abdominal aortic aneurism.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      50 patients is scheduled for enrollment. Blood samples will be up taken before surgery, 10
      min after reperfusion, at the end of surgery and the following morning. In addition the
      investigators are placing a renal venous catheter where blood samples will be up taken as
      mentioned above for the analysis of endothelial markers together with markers for kidney
      damage.

      The first 10 patient will act as part of a pilot study, where only measurement of the
      endothelial and renal failure markers will be performed.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial dysfunction</measure>
    <time_frame>24 hours</time_frame>
    <description>Measurement of endothelial markers peri- and postoperative: thrombomodulin, E-selectin and syndecan-1</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fluid balance</measure>
    <time_frame>24 hours</time_frame>
    <description>Perioperative and postoperative first 24 hours</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Postoperative organ failure</measure>
    <time_frame>30 days</time_frame>
    <description>Development of kidney- and respiratory failure and sepsis</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Abdominal Aortic Aneurism</condition>
  <condition>Surgery</condition>
  <condition>Ischemic Reperfusion Injury</condition>
  <arm_group>
    <arm_group_label>Fresh frozen plasma</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 portions of FFP will be transfused prior to reperfusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fresh non-frozen plasma</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 portions of non-frozen plasma will be transfused prior to reperfusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Plasma</intervention_name>
    <description>2 Units of plasma transfused equvilant to 2 times 275ml</description>
    <arm_group_label>Fresh frozen plasma</arm_group_label>
    <arm_group_label>Fresh non-frozen plasma</arm_group_label>
    <other_name>Fresh frozen plasma versus fresh non-frozen plasma</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  above 18 years

        Exclusion Criteria:

          -  prior engagement in scientific study within the last 30 days.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Per I Johansson, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Section for Transfusion Medicine, Capital Region Blood Bank, Rigshospitalet, Copenhagen, Denmark.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas B Jørgensen, MD</last_name>
    <phone>+4535458734</phone>
    <email>thomas.bech.aaa@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <state>Østerbro</state>
        <zip>2000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas B Jørgensen, MD</last_name>
      <phone>+4535458734</phone>
      <email>thomas.bech.aaa@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Thomas B Jørgensen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2013</study_first_submitted>
  <study_first_submitted_qc>April 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 17, 2013</study_first_posted>
  <last_update_submitted>April 16, 2013</last_update_submitted>
  <last_update_submitted_qc>April 16, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 17, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Thomas Bech Jorgensen</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Abdominal Aortic Aneurism</keyword>
  <keyword>Endothelia</keyword>
  <keyword>Glycocalyx</keyword>
  <keyword>Reperfusion</keyword>
  <keyword>Plasma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
    <mesh_term>Reperfusion Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

